Absorb Gt1
Payments companies reported to CMS as associated with Absorb Gt1. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Absorb Gt1, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Absorb Gt1
These are the largest totals companies reported as associated with Absorb Gt1. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Gregg Stone | New York, NY | Cardiovascular Disease | $8,795.44 |
| Johnathon Rollo | Los Angeles, CA | Vascular Surgery | $163.56 |
| William Duong | Loma Linda, CA | Vascular Surgery | $163.55 |
| Jivan Melikian | Glendale, CA | Cardiovascular Disease | $140.75 |
| Kevin Croce | Chestnut Hill, MA | Cardiovascular Disease | $128.39 |
| Rajiv Swamy | Sanford, NC | Interventional Cardiology | $107.23 |
| John Lane | San Diego, CA | Vascular Surgery | $89.29 |
| Kathleen Kearney | Seattle, WA | Interventional Cardiology | $48.88 |
| Barry Bertolet | Tupelo, MS | Cardiovascular Disease | $28.38 |
| Nicole Brock | Aurora, CO | Adult Health (Nurse Practitioner) | $27.86 |
Prescribed Absorb Gt1?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.